IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection

Imanis Life Sciences

Menu

Knowing your SARS-CoV-2 neutralizing antibody titer matters?

June 22, 2021, Imanis Life Sciences, Rochester MN

Neutralizing antibodies for SARS-CoV-2 prevent the virus from entering healthy cells and directly correlate to a person’s level of protection from future infection. SARS-CoV-2 vaccines stimulate the immune system to produce neutralizing antibodies.

But months after vaccination, neutralizing antibody levels drop. Many immune compromised individuals also don’t produce protective levels of neutralizing antibodies following vaccination.

The Imanis IMMUNO-COV assay accurately measures the level of SARS-CoV-2-neutralizing antibodies in vaccinated individuals and those recovering from natural infections, so that they can better understand the risks associated with daily activities and whether they should take extra precautions.

Continue reading.

Learning Resources

Stay Informed

Stay up to date on the latest from the Imanis team, including product releases, promotional codes, and exciting new advancements in noninvasive in vivo imaging!